Swipe om te navigeren naar een ander artikel
The online version of this article (doi:10.1007/s10803-009-0878-1) contains supplementary material, which is available to authorized users.
All authors remain at the same institutions that they were at during the study.
Patterns of current psychotropic medication use among 5,181 children with autism spectrum disorders (ASD) enrolled in a Web-based registry were examined. Overall, 35% used at least one psychotropic medication, most commonly stimulants, neuroleptics, and/or antidepressants. Those who were uninsured or exclusively privately insured were less likely to use ≥3 medications than were those insured by Medicaid. Psychiatrists and neurologists prescribed the majority of psychotropic medications. In multivariate analysis, older age, presence of intellectual disability or psychiatric comorbidity, and residing in a poorer county or in the South or Midwest regions of the United States increased the odds of psychotropic medication use. Factors external to clinical presentation likely affect odds of psychotropic medication use among children with ASD.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
(DOC 35 kb)10803_2009_878_MOESM1_ESM.doc
American Society of Health System Pharmacists. (2006). AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists.
American Psychiatric Association. (2000). Disorders usually first diagnosed in infancy, childhood, or Adolescence. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR) (Fourth, Text Revision ed.). Arlington, VA: American Psychiatric Association. doi: 10.1176/appi.books.9780890423349.
Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999). Autism screening questionnaire: Diagnostic validity. The British Journal of Psychiatry: The Journal of Mental Science, 175, 444–451. CrossRef
Best, S. J., & Krueger, B. S. (2004). Internet data collection. Thousand Oaks, CA: Sage.
Bryson, S. E., Rogers, S. J., & Fombonne, E. (2003). Autism spectrum disorders: Early detection, intervention, education, and psychopharmacological management. Canadian Journal of Psychiatry (Revue Canadienne De Psychiatrie), 48(8), 506–516.
Farmer, J. E., Marvine, A., Law, K., & Anderson, C. (2009). The impact of urbanicity on diagnosis and treatment of ASD. Presented at IMFAR, Chicago, IL.
Filipek, P. A., Accardo, P. J., Ashwal, S., Baranek, G. T., Cook, E. H., Jr, Dawson, G., et al. (2000). Practice parameter: Screening and diagnosis of autism: Report of the quality standards subcommittee of the American academy of neurology and the child neurology society. Neurology, 55(4), 468–479. PubMed
Findling, R. L. (2005). Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders. The Journal of Clinical Psychiatry, 66(Suppl 10), 26–31. PubMed
Hewson, C., Yule, P., Laurent, D., & Vogel, C. (2003). Internet research methods: A practical guide for the social and behavioral sciences. London: Sage.
Hoagwood, K., Jensen, P. S., Feil, M., Vitiello, B., & Bhatara, V. S. (2000). Medication management of stimulants in pediatric practice settings: A national perspective. Journal of Developmental and Behavioral Pediatrics: JDBP, 21(5), 322–331. PubMed
Jones, S., & Fox, S. (2009) Generations online in 2009. Pew Internet and American life project. http://www.pewinternet.org/Reports/2009/Generations-Online-in-2009. Accessed May 20, 2009.
Martin, A., Sherwin, T., Stubbe, D., Van Hoof, T., Scahill, L., & Leslie, D. (2002). Datapoints: Use of multiple psychotropic drugs by medicaid-insured and privately insured children. Psychiatric Services (Washington, D.C.), 53(12), 1508.
National Center for Health Statistics. (2006) NCHS urban–rural classification scheme for counties. Retrieved November 15, 2008, from http://www.cdc.gov/nchs/r&d/rdc_urbanrural.htm.
Safer, D. J., Zito, J. M., & Gardner, J. F. (2004). Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths. Psychiatric Services (Washington, D.C.), 55(9), 1049–1051.
Tsai, L. Y. (1999). Psychopharmacology in autism. Psychosomatic Medicine, 61(5), 651–665. PubMed
US Census Bureau. (2008). Retrieved October 31, 2008, from http://factfinder.census.gov.
Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. (2005). Effect of medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services (Washington, D.C.), 56(2), 157–163.
- Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008
Rebecca E. Rosenberg
David S. Mandell
Janet E. Farmer
J. Kiely Law
Alison R. Marvin
Paul A. Law
- Springer US